Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
about
A Role for the Brain RAS in Alzheimer's and Parkinson's DiseasesPathophysiological links between traumatic brain injury and post-traumatic headachesProtective Microglia and Their Regulation in Parkinson's DiseaseBrain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort studyTelmisartan protects central neurons against nutrient deprivation-induced apoptosis in vitro through activation of PPARγ and the Akt/GSK-3β pathway.Brain renin-angiotensin system and dopaminergic cell vulnerabilityPPAR-γ agonist GW1929 but not antagonist GW9662 reduces TBBPA-induced neurotoxicity in primary neocortical cells.Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways.Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders.Importance of the brain Angiotensin system in Parkinson's diseaseImmunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease.Neurorestoration after traumatic brain injury through angiotensin II receptor blockageBrain angiotensin and dopaminergic degeneration: relevance to Parkinson's diseaseSurgery-Induced Hippocampal Angiotensin II Elevation Causes Blood-Brain Barrier Disruption via MMP/TIMP in Aged Rats.Extracts of Tripterygium wilfordii Hook F in the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis of Randomised Controlled Trials.Curcumin Attenuates Beta-Amyloid-Induced Neuroinflammation via Activation of Peroxisome Proliferator-Activated Receptor-Gamma Function in a Rat Model of Alzheimer's Disease.Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTP.The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonismA survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets.Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease.Neuroprotective effects of angiotensin receptor blockers.Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions.Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation.Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration.Temporal Changes in Cortical and Hippocampal Expression of Genes Important for Brain Glucose Metabolism Following Controlled Cortical Impact Injury in Mice.The role of local renin-angiotensin system on high glucose-induced cell toxicity, apoptosis and reactive oxygen species production in PC12 cellsTelmisartan Activates PPARδ to Improve Symptoms of Unpredictable Chronic Mild Stress-Induced Depression in Mice.Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease.Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury.The pharmacological research of Tek-1 relevance to anti-neuroinflammation, a candidate compound based on Telmisartan.
P2860
Q26861984-E481F055-416E-45A2-BAF5-C0A31709A49EQ28067288-76364C2F-1FBC-4734-988F-42CE20895E08Q28079731-1CAFC2A3-5696-46CA-B35A-331290BD7E47Q33627982-C808F72C-FCF8-487B-AE30-CA111202EFEFQ33727268-7DDFAE39-E750-4E06-800D-E3140B0653ADQ33861931-A3EF0579-8E0D-4583-87CE-E2E7651FABDFQ33861951-381523B4-8C41-486A-AEFC-557338540282Q35019416-D7C13258-9B4C-4DAB-BF69-F1553AAF5863Q36136825-9F0D9B44-1DAB-4E49-A7B9-D5F1ECA732C5Q36148314-0A602416-714F-4551-9176-C2DEEC8FE294Q36415423-1F1AF05D-1B16-4E7F-9529-B5015B8B3080Q36474039-A15970C9-C438-4257-96DA-2701CA4FA9A6Q36515931-C77FBA1C-25EC-45F1-8C02-96BE3832DFABQ36576487-18E0BEED-84A7-4B63-B0B3-4505FB98A886Q36834432-C2C6E637-9EF0-4F4D-91EC-1CF1D3CD2DC4Q36896228-88548CF4-0A06-416C-A341-11DCA0F2B5FEQ37188527-A54C8AEF-FC29-4146-99C0-B9C00E633491Q37256315-A6CA67B1-8A40-4BFC-B4AE-B9C3C80400B7Q37467929-67288E03-27F8-4FC4-8B6F-89195EF087C7Q38111109-F277465D-EE38-489F-883B-E41B21D95BC7Q38127396-7CA40D1F-733A-415F-8C7E-32155F6ECACDQ38264237-6B58E779-DBA1-4F7C-A9D8-653D3FEFA763Q38461657-9E096E00-568F-406D-9288-032A820DB962Q38715896-0CB2B2DA-8981-46FD-8DF1-BD17C5017F3BQ38834345-C05D6E1E-74CD-4B26-81D7-C68C45B1623DQ41684033-5AB8E025-492C-4A2A-A078-15D318628E93Q41895132-53DEF9A0-FB8D-40A0-8FED-9F449CA9B262Q42630308-2E0F87E1-BDF7-4EDA-A149-5ED8E449BC79Q43679571-D995247D-2E00-42F6-A23E-2AB0350534C0Q46316918-9208B25D-3A61-43B7-BAB8-7100369895C4Q50526982-930D235E-C05B-42F7-9AB1-057869D53DF1Q51612114-B78F8B9A-7050-46FF-B53E-8F0570C1F089Q53250189-D2D6DA12-496B-4A02-8802-1288098B29E7
P2860
Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Involvement of PPAR-γ in the n ...... model of Parkinson's disease.
@ast
Involvement of PPAR-γ in the n ...... model of Parkinson's disease.
@en
type
label
Involvement of PPAR-γ in the n ...... model of Parkinson's disease.
@ast
Involvement of PPAR-γ in the n ...... model of Parkinson's disease.
@en
prefLabel
Involvement of PPAR-γ in the n ...... model of Parkinson's disease.
@ast
Involvement of PPAR-γ in the n ...... model of Parkinson's disease.
@en
P2093
P2860
P356
P1476
Involvement of PPAR-γ in the n ...... P model of Parkinson's disease
@en
P2093
Belen Joglar
Jose L Labandeira-Garcia
Maria J Guerra
Pablo Garrido-Gil
P2860
P2888
P356
10.1186/1742-2094-9-38
P577
2012-02-22T00:00:00Z
P5875
P6179
1011641855